Notice Title

Consent to the Distribution of a New Medicine

Publication Date
25 Aug 2022

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2022-go3553
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Pulmozyme
Active Ingredient: Dornase alfa 1mg/mL
Dosage Form: Solution for inhalation
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturers: Genentech Inc, California, United States of America
Woodstock Sterile Solutions, Inc., Illinois, United States of America


Dated this 22nd day of August 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).